These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7396175)

  • 41. [Immuno-hemolytic transfusion reactions. III. Report of 61 cases].
    Le Pennec PY; Tissier AM; Mannessier L; Agulles O; Babinet J; Bidet ML; Bombail-Girard D; Cabaud JJ; Cartron J; Chiaroni J; Desaint C; Krause C; Lamy B; Meyer F; Mortelecque R; Nafissi S; Rasongles P; Schweitzer B; Rouger P
    Transfus Clin Biol; 1996; 3(3):157-65. PubMed ID: 8925110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. False-negative compatible antiglobulin crossmatches in samples with alloantibodies to cognate red blood cell antigens.
    Nixon CP; Krohto SL; Sweeney JD
    Transfusion; 2018 Aug; 58(8):2022-2026. PubMed ID: 29687886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion.
    Heddle NM; Soutar RL; O'Hoski PL; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1995 Dec; 91(4):1000-5. PubMed ID: 8547111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete disappearance of ABO antigen-a cause of ABO discrepancy.
    Das S; Kumar V; Jafa E; Basavarajegowda A; Kayal S
    Transfusion; 2018 Jan; 58(1):5-6. PubMed ID: 29314104
    [No Abstract]   [Full Text] [Related]  

  • 45. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
    Irani MS; Karafin MS; Ernster L
    J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Detection and analysis of ABO Hemolytic disease in newborn].
    Lin ZX; Dong QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1432-4. PubMed ID: 25338602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative and claims data.
    Carnahan RM; Kee VR
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():230-5. PubMed ID: 22262610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Compatibility tests and pre-transfusion precautions].
    Andre A
    Acta Anaesthesiol Belg; 1970; 21(1):69-87. PubMed ID: 4997382
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immune hemolytic anemia caused by antibodies of the ABO system following ABO-incompatible kidney transplantation. Gm allotyping of the immune antibody].
    Bein G; Poschmann A; Rob P
    Beitr Infusionsther; 1988; 21():251-4. PubMed ID: 2462986
    [No Abstract]   [Full Text] [Related]  

  • 51. Medicolegal assessment of blood transfusion errors--an interdisciplinary challenge.
    Padosch SA; Schmidt PH; Pedal I; Franchy C; Hoch J; Madea B
    Forensic Sci Int; 2007 Oct; 172(1):40-8. PubMed ID: 17222999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limiting the extent of a delayed hemolytic transfusion reaction with automated red blood cell exchange.
    Tormey CA; Stack G
    Arch Pathol Lab Med; 2013 Jun; 137(6):861-4. PubMed ID: 23721278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute transfusion reactions.
    Henderson RA; Pinder L
    N Z Med J; 1990 Oct; 103(900):509-11. PubMed ID: 2234645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Transfusion of incompatible blood from the aspect of forensic serology].
    Klír P; Stefan J
    Soud Lek; 1989 Aug; 34(3):33-6. PubMed ID: 2799436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Yes, we should keep ABO agglutination test within bedside transfusion checks].
    Daurat G
    Transfus Clin Biol; 2008 Nov; 15(5):322-6. PubMed ID: 18930425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatal hemolytic transfusion reaction resulting from ABO mistyping of a patient with acquired B antigen detectable only by some monoclonal anti-B reagents.
    Garratty G; Arndt P; Co A; Rodberg K; Furmanski M
    Transfusion; 1996 Apr; 36(4):351-7. PubMed ID: 8623139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Good laboratory practice before blood transfusion.
    Moore BP
    Can Med Assoc J; 1984 Jun; 130(11):1421-3. PubMed ID: 6428727
    [No Abstract]   [Full Text] [Related]  

  • 59. Monogamous bivalency of IgG antibodies. I. Deficiency of branched ABHI-active oligosaccharide chains on red cells of infants causes the weak antiglobulin reactions in hemolytic disease of the newborn due to ABO incompatibility.
    Romans DG; Tilley CA; Dorrington KJ
    J Immunol; 1980 Jun; 124(6):2807-11. PubMed ID: 7189535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on Serological Blood Group Conversion in BM Empty Phase of ABO-incompatible Allogeneic Stem Cell Transplantation].
    Cai XJ; Chen BL; Xie ZT; Ye YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):221-4. PubMed ID: 26913424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.